Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial (Q39276881)

10 September 2017

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial (English)

1 reference

10 September 2017

0 references

anti-retroviral agent

0 references

1 reference

15

Lehana Thabane

1 reference

10 September 2017

13

Elizabeth Ngugi

1 reference

10 September 2017

17

Joshua Kimani

1 reference

10 September 2017

19

Francis A Plummer

1 reference

10 September 2017

3

Edward J Mills

1 reference

10 September 2017

16

Lawrence J Gelmon

1 reference

10 September 2017

4

Antony Kariri

1 reference

10 September 2017

8

James Habyarimana

1 reference

10 September 2017

5

Sarah Karanja

1 reference

10 September 2017

12

Benson Estambale

1 reference

10 September 2017

18

Marta Ackers

1 reference

10 September 2017

Richard T Lester

1

1 reference

10 September 2017

Paul Ritvo

2

1 reference

10 September 2017

Michael H Chung

6

1 reference

10 September 2017

William Jack

7

1 reference

10 September 2017

Mohsen Sadatsafavi

9

1 reference

10 September 2017

Mehdi Najafzadeh

10

1 reference

10 September 2017

Carlo A Marra

11

1 reference

10 September 2017

T Blake Ball

14

1 reference

10 September 2017

language of work or name

English

0 references

publication date

9 November 2010

1 reference

10 September 2017

1 reference

10 September 2017

376

1 reference

10 September 2017

9755

1 reference

10 September 2017

1838-1845

1 reference

Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries?

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

1 reference

7 January 2021

Healthcare via cell phones: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

The impact of HIV scale-up on health systems: A priority research agenda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Unequal group sizes in randomised trials: guarding against guessing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Cell phones: tightening the communication gap in resource-limited antiretroviral programmes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Adjusting for multiple testing in studies is less important than other concerns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Confidence intervals for the number needed to treat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Access, use and perceptions regarding Internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Can antiretroviral therapy eliminate HIV transmission?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Home Visits to Improve Adherence to Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Explaining adherence success in sub-Saharan Africa: an ethnographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

Current trends in Internet- and cell phone-based HIV prevention and intervention programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961997-6

7 January 2021

10.1016/S0140-6736(10)61997-6

Identifiers

DOI

1 reference

10 September 2017

1 reference